 | Up a level |
Hyman, David M., Tran, Ben, Paz-Ares, Luis, Machiels, Jean-Pascal, Schellens, Jan H., Bedard, Philippe L., Campone, Mario, Cassier, Philippe A., Sarantopoulos, John, Vaishampayan, Ulka, Chugh, Rashmi, Mahipal, Amit, Lockhart, A. Craig, Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe 
ORCID: 0000-0003-1781-2518, Bendiske, Jennifer, Chen, Xueying, Choudhury, Somesh, Graus-Porta, Diana, Lewis, Nancy, Perez Garcia, Jose Manuel and Jose de Miguel-Luken, Maria
(2019).
Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations.
JCO Precis. Oncol., 3.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 2473-4284
Hyman, David Michael, Jaime, Jesus Corral, Garralda, Elena, Machiels, Jean-Pascal H., Schellens, Jan H. M., Bedard, Phillipe, Campone, Mario, Cassier, Philippe, Sarantopoulos, John, Vaishampayan, Ulka N., Chugh, Rashmi ORCID: 0000-0002-4633-6971, Mahipal, Amit, Lockhart, Albert C., Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe ORCID: 0000-0003-1781-2518, Bendiske, Jennifer and Perez-Garcia, Jose Manuel
(2016).
Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755